ddp4 and glp 1 Neuroprotection by dipeptidyl-peptidase-4 inhibitors glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease DPP-4 inhibitors and GLP-1RAs: cardiovascular
Description
The DEA, FBI, TSA, and other federal law enforcement agencies use drug testing programs consistent with federal SAMHSA guidelines
Riddy, D
Usui R, Yabe D, Seino Y
Enhanced AMPA receptor trafficking mediates the anorexigenic effect of endogenous glucagon-like peptide-1 in the paraventricular hypothalamus
Hazard ratio, 0.78 (95% CI, 0.66-0.93)
Patients who need long-term weight management support
